018430217

KRASLOQ

---

March 16, 2021

Trademark Summary

The trademark application KRASLOQ was filed by Mirati Therapeutics, Inc.,, a U.S. corporation (the "Applicant"). The application was published for oppositions on April 11, 2021, and it was registered by office on July 19, 2021 without any oppositions.

The application was filed in English (French was selected as the second language).

Change of name and address of the trademark registration was recorded on June 29, 2021. Appointment and Replacement of representative of the trademark registration was recorded on August 5, 2021.

---

Goods And Services

• The mark was filed in class 5 with following description of goods:
  
  1. Pharmaceuticals
  2. Pharmaceutical preparations
  3. Pharmaceutical products
  4. Pharmaceutical preparations for the treatment of cancer
  5. Pharmaceutical preparations for use in oncology
  6. Pharmaceutical preparations for the treatment of infectious diseases
  7. Pharmaceutical preparations for the treatment of lung cancer
  8. Pharmaceutical preparations for the treatment of non-small cell lung carcinoma
  9. Pharmaceutical preparations for the treatment of colorectal carcinoma
  10. Pharmaceutical preparations for the treatment of pancreatic cancer
  11. Pharmaceuticals comprising small molecules
  12. Pharmaceuticals comprising small molecules for the treatment of cancer
  13. Pharmaceuticals comprising small molecules for the treatment of infectious diseases
  14. Pharmaceuticals comprising small molecules for the treatment of lung cancer
  15. Pharmaceuticals comprising small molecules for the treatment of non-small cell lung carcinoma
  16. Pharmaceuticals comprising small molecules for the treatment of colorectal carcinoma
  17. Pharmaceuticals comprising small molecules for the treatment of pancreatic cancer
  18. Pharmaceuticals comprising compounds
  19. Pharmaceuticals comprising compounds for the treatment of cancer
  20. Pharmaceuticals comprising inhibitors
  21. Pharmaceuticals comprising inhibitors for the treatment of cancer
  22. Pharmaceuticals for the treatment of solid tumors
  23. Pharmaceuticals for the treatment of advanced solid tumors.
• The mark was filed in class 42 with following description of goods:
  
  1. Research and development of pharmaceuticals in the field of oncology
  2. Providing information in the field of scientific and medical research related to oncology
  3. Research and development of pharmaceuticals
  4. Providing information in the field of scientific and medical research related to pharmaceuticals.